What Matters Most for Long-Acting Antiretroviral Therapy? A Best-Worst Scaling Discrete Choice Experiment. Fisk-Hoffman RJ, Liu Y, Somboonwit C, Widmeyer M, et al. J Acquir Immune Defic Syndr 2025 Jan 21. doi: 10.1097/QAI.0000000000003609.

Read + Share

Amedeo Smart

Independent Medical Education

Fisk-Hoffman RJ, Liu Y, Somboonwit C, Widmeyer M, et al. What Matters Most for Long-Acting Antiretroviral Therapy? A Best-Worst Scaling Discrete Choice Experiment. J Acquir Immune Defic Syndr 2025 Jan 21. doi: 10.1097/QAI.0000000000003609.
PMID: 39834007